| Pharmaceutical Information |
| Drug Name |
Streptokinase |
| Drug ID |
BADD_D02070 |
| Description |
Streptokinase, is a sterile, purified preparation of a bacterial protein elaborated by group C (beta) -hemolytic streptococci. |
| Indications and Usage |
For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or emolism and occlusion of arteriovenous cannulae |
| Marketing Status |
approved; investigational |
| ATC Code |
B01AD01 |
| DrugBank ID |
DB00086
|
| KEGG ID |
D06879
|
| MeSH ID |
D013300
|
| PubChem ID |
9815560
|
| TTD Drug ID |
D04URO
|
| NDC Product Code |
Not Available |
| UNII |
8X1OXL3SNU
|
| Synonyms |
Streptokinase | Streptase | Streptodecase | Kabikinase | Awelysin | Celiase | Distreptase | Kabivitrum | Avelizin |
|
| Chemical Information |
| Molecular Formula |
C11H19NO2 |
| CAS Registry Number |
9002-01-1 |
| SMILES |
C1CCC(CC1)C2CC(NC2)C(=O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
